Showing results (701-710 of 887) with videos related to
Sort By:
Pageof 89
Clinical Nuclear Medicine|June 20, 2020
177Lu-/68Ga-PSMA Theranostics in Recurrent Glioblastoma Multiforme: Proof of ConceptArunav Kumar, Sanjana Ballal, Madhav Prasad Yadav, et al.Antimicrobial Agents and Chemotherapy|February 25, 2005
Pharmacokinetics of gatifloxacin in infants and childrenEdmund V Capparelli, Michael D Reed, John S Bradley, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|June 24, 2009
Maraviroc concentrates in the cervicovaginal fluid and vaginal tissue of HIV-negative womenJulie B Dumond, Kristine B Patterson, Allison L Pecha, et al.Blood|August 10, 2012
T-cell independent, B-cell receptor-mediated induction of telomerase activity differs among IGHV mutation-based subgroups of chronic lymphocytic leukemia patientsRajendra N Damle, Sonal Temburni, Taraneh Banapour, et al.British Journal of Clinical Pharmacology|May 15, 2023
Effects of itraconazole and carbamazepine on the pharmacokinetics of nirmatrelvir/ritonavir in healthy adultsDonna S Cox, Lien Van Eyck, Sylvester Pawlak, et al.Journal of Medical Case Reports|September 17, 2010
Adult growth hormone deficiency treatment with a combination of growth hormone and insulin-like growth factor-1 resulting in elevated sustainable insulin-like growth factor-1 and insulin-like growth factor binding protein 3 plasma levels: a case reportEric R Braverman, Abdalla Bowirrat, Uma J Damle, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2006
Antitumor efficacy of a combination of CMC-544 (inotuzumab ozogamicin), a CD22-targeted cytotoxic immunoconjugate of calicheamicin, and rituximab against non-Hodgkin's B-cell lymphomaJohn F DiJoseph, Maureen M Dougher, Lyka B Kalyandrug, et al.World Journal of Surgery|June 5, 2025
Giant Parathyroid Adenomas: A 28-Year Experience at a Tertiary Super-Specialty HospitalGopal Puri, Piyush Ranjan, Brijesh Kumar Singh, et al.Nucleic Acids Research|October 30, 2025
Discovery of long-acting APOC3 siRNA for treating patients with hypertriglyceridemiaThazha P Prakash, Adam E Mullick, Stan Riney, et al.Toxicologic Pathology|June 15, 1999
BR96 sFv-PE40 immunotoxin: nonclinical safety assessmentH G Haggerty, W A Warner, C R Comereski, et al.Pageof 89